Clinical Trials Browser

Phase 2 × Rectal Neoplasms × Imatinib Mesylate × Clear all

NCT00041340 2013-01-23

Imatinib Mesylate in Treating Patients With Stage IV Colorectal Cancer

Phase 2 Completed

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms